Tenax Therapeutics Inc (TENX)
3.549
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
3.66
+0.11
(+3.13%)
After-Hours: 20:00
Tenax Therapeutics Cash from Operations (Quarterly): -1.174M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.174M |
| September 30, 2023 | -2.081M |
| June 30, 2023 | -0.923M |
| March 31, 2023 | -1.725M |
| December 31, 2022 | -1.689M |
| September 30, 2022 | -3.331M |
| June 30, 2022 | -3.431M |
| March 31, 2022 | -2.938M |
| December 31, 2021 | -2.768M |
| September 30, 2021 | -3.022M |
| June 30, 2021 | -1.845M |
| March 31, 2021 | -3.221M |
| December 31, 2020 | -1.987M |
| September 30, 2020 | -2.385M |
| June 30, 2020 | -2.229M |
| March 31, 2020 | -2.671M |
| December 31, 2019 | -1.726M |
| September 30, 2019 | -1.782M |
| June 30, 2019 | -1.915M |
| March 31, 2019 | -2.133M |
| December 31, 2018 | -1.198M |
| September 30, 2018 | -1.556M |
| June 30, 2018 | -1.188M |
| March 31, 2018 | -1.558M |
| December 31, 2017 | -1.282M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.226M |
| June 30, 2017 | -5.595M |
| March 31, 2017 | -4.037M |
| December 31, 2016 | -3.105M |
| September 30, 2016 | -4.281M |
| June 30, 2016 | -5.166M |
| March 31, 2016 | -3.320M |
| October 31, 2015 | -2.702M |
| July 31, 2015 | -3.843M |
| April 30, 2015 | -1.627M |
| March 31, 2015 | -2.543M |
| January 31, 2015 | -3.227M |
| October 31, 2014 | -2.912M |
| July 31, 2014 | -1.982M |
| April 30, 2014 | -2.980M |
| January 31, 2014 | -2.705M |
| October 31, 2013 | -2.013M |
| July 31, 2013 | -1.563M |
| April 30, 2013 | -1.440M |
| January 31, 2013 | -0.739M |
| October 31, 2012 | -1.129M |
| July 31, 2012 | -1.613M |
| April 30, 2012 | -1.421M |
| January 31, 2012 | -2.274M |
| October 31, 2011 | -2.530M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-3.431M
Minimum
Jun 2022
-0.923M
Maximum
Jun 2023
-2.255M
Average
-2.081M
Median
Sep 2023
Cash from Operations (Quarterly) Benchmarks
| CEL-SCI Corp | -4.528M |
| AIM ImmunoTech Inc | -9.758M |
| IGC Pharma Inc | -1.587M |
| NovaBay Pharmaceuticals Inc | -1.572M |
| Protalix BioTherapeutics Inc | 4.188M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | -0.1745M |
| Free Cash Flow | -5.904M |
| Free Cash Flow Per Share (Quarterly) | -3.930 |
| Free Cash Flow Yield | -672.2% |